Added to YB: 2025-09-10
Pitch date: 2025-09-08
MREO [neutral]
Mereo BioPharma Group plc
+15.38%
current return
Author Info
Raging Bull Investments is a lawyer by background who shares actionable investment ideas on value opportunities with a catalyst. Sign up for the newsletter.
Company Info
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally.
Market Cap
$281.6M
Pitch Price
$1.82
Price Target
N/A
Dividend
N/A
EV/EBITDA
-5.22
P/E
-5.60
EV/Sales
452.15
Sector
Biotechnology
Category
special_situation
Raging Bull Investments | Idea Update - 9/8/2025 - Mereo BioPharma (Closing)
MREO closed position: Biotech bet failed as alvelestat partnership never materialized despite CEO promises, leaving firm exposed for setrusumab trial. Second interim analysis missed early success threshold, shares collapsed. Bull case remains (final analysis could work, potential alvelestat deal) but amounts to gambling without edge.
Read full article (2 min)